2014
On the molecular pharmacology of resveratrol on oxidative burst inhibition in professional phagocytes
NOSÁL, Radomír; Katarína DRÁBIKOVÁ; Viera JANČINOVÁ; Tomáš PEREČKO; Gabriela AMBROŽOVÁ et al.Základní údaje
Originální název
On the molecular pharmacology of resveratrol on oxidative burst inhibition in professional phagocytes
Název česky
On the molecular pharmacology of resveratrol on oxidative burst inhibition in professional phagocytes
Název anglicky
On the molecular pharmacology of resveratrol on oxidative burst inhibition in professional phagocytes
Autoři
NOSÁL, Radomír; Katarína DRÁBIKOVÁ; Viera JANČINOVÁ; Tomáš PEREČKO; Gabriela AMBROŽOVÁ; Milan ČÍŽ; Antonín LOJEK; Michaela PEKAROVÁ; Jan ŠMIDRKAL a Juraj HARMATHA
Vydání
Oxidative Medicine and Cellular Longevity, New York, Hindawi Publishing Corporation, 2014, 1942-0900
Další údaje
Typ výsledku
Článek v odborném periodiku
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.516
Označené pro přenos do RIV
Ne
Klíčová slova česky
Resveratrol, Oxidative Burst, Professional Phagocytes
Klíčová slova anglicky
Resveratrol, Oxidative Burst, Professional Phagocytes
Změněno: 19. 1. 2017 00:56, Mgr. Michaela Pekarová, Ph.D.
V originále
Resveratrol—3,5,4′-trihydroxystilbene—possesses antioxidant activities in vitro. It dose-dependently inhibited the generation of peroxyl, hydroxyl, peroxides, and lipid peroxidation products in cell free systems. Oxidative burst of whole human blood stimulated with PMA, fMLP, OpZ, and A23187 was inhibited in a concentration-dependent way, indicating suppression of both receptor and nonreceptor activated chemiluminescence by resveratrol. Results from isolated human neutrophils revealed that resveratrol was active extracellularly as well as intracellularly in inhibiting the generation of reactive oxygen species. Liberation of ATP and analysis of apoptosis showed that in the concentration of 100 μM, resveratrol did not change the viability and integrity of isolated neutrophils. Western blot analysis documented that resveratrol in concentrations of 10 and 100 μM significantly decreased PMA-induced phosphorylation of PKC α/βII. Dose-dependent inhibition of nitrite production and iNOS protein expression in RAW 264.7 cells indicated possible interference of resveratrol with reactive nitrogen radical generation in professional phagocytes. The results suggest that resveratrol represents an effective naturally occurring substance with potent pharmacological effect on oxidative burst of human neutrophils and nitric oxide production by macrophages. It should be further investigated for its pharmacological activity against oxidative stress in ischaemia reperfusion, inflammation, and other pathological conditions, particularly neoplasia.
Česky
Resveratrol—3,5,4′-trihydroxystilbene—possesses antioxidant activities in vitro. It dose-dependently inhibited the generation of peroxyl, hydroxyl, peroxides, and lipid peroxidation products in cell free systems. Oxidative burst of whole human blood stimulated with PMA, fMLP, OpZ, and A23187 was inhibited in a concentration-dependent way, indicating suppression of both receptor and nonreceptor activated chemiluminescence by resveratrol. Results from isolated human neutrophils revealed that resveratrol was active extracellularly as well as intracellularly in inhibiting the generation of reactive oxygen species. Liberation of ATP and analysis of apoptosis showed that in the concentration of 100 μM, resveratrol did not change the viability and integrity of isolated neutrophils. Western blot analysis documented that resveratrol in concentrations of 10 and 100 μM significantly decreased PMA-induced phosphorylation of PKC α/βII. Dose-dependent inhibition of nitrite production and iNOS protein expression in RAW 264.7 cells indicated possible interference of resveratrol with reactive nitrogen radical generation in professional phagocytes. The results suggest that resveratrol represents an effective naturally occurring substance with potent pharmacological effect on oxidative burst of human neutrophils and nitric oxide production by macrophages. It should be further investigated for its pharmacological activity against oxidative stress in ischaemia reperfusion, inflammation, and other pathological conditions, particularly neoplasia.